Monday, July 7, 2008

The dilemna of high cost and minimal benefit

The link below will take you to a New York Times article that discusses the cost and the benefits of Avastin. Avastin is a very expensive cancer drug.

The article does a good job of describing Avastin and the dilemna of having an expensive drug with limited benefits.

http://tinyurl.com/6443c5

No comments: